Show simple item record

dc.contributor.authorKimari, Francis C
dc.date.accessioned2013-05-11T08:09:56Z
dc.date.issued2006
dc.identifier.citationMBAen
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/21740
dc.description.abstractAs organisations streamline their production and internal processes, the next opportunity for improvement is through better coordination and networking with their suppliers and customers through the supply chain. Much of the cost and value creation occur in the supply and distribution chain. The purpose of value chain is to attain full and seamless interaction among stakeholders to create a win-win situation. Identification and analysis of cost of activities and the roles played in a business processes from production to sales has great potential in unlocking value. This study focuses on the supply and distribution of Pharmaceutical products in Kenya. The research work was to investigate the pharmaceutical producers' and end users' perceptions on the role and value contributed by distributors in the provision of medical supplies in Kenya using the Value chain concept. Players.in the medical supply chain in Kenya are spread over the whole country. The population consisted of two groups; the producer and end users each relatively homogeneous. With a constrained budget and time limitations, a representative sample from each stratum of the population was used. To ensure adequate representation different, stratified probability sampling method was used in selecting the sampling units from each of the sampling frame. The sample size took account of the dispersion of the population, the desired level of accuracy and interval range. A structured questionnaire was used to collect primary data. Secondary data was obtained from the company's management information system and printed records. Analysis of the data was done by commercial SPSS software and Microsoft Excel spreadsheet. One of the key findings from the study was that 76% of the producers channelled out up to one half of their businesses through the distributors while 24% relied on distributors to sell more than half of the products manufactured or imported. It also emerged that half of the users sourced more than one half of their stocks from distributors. This finding indicates heavy reliance on the distributor to put through products in the supply chain. The study also found out that both producers and users were most satisfied, mean 3.80 and 3.45 respectively on a scale of 1-5, with the distributors' ability to promptly deliver products upon order placements. The producers were least satisfied (mean 2.17) with the amount of discounts and commissions demanded by the distributors. It was also found out users were least satisfied (mean 2.93) with distributors' lack of value adding services such as product information/support and marketing. Further, ownership of products remained in the producers until they were sold. Thus any losses resulting from expired or unsold products were fully incurred by producers. The study recommended that their operations especially with producers be guided by professionally done contracts to rule out exploitation or intimidation. It was also recommended that the government gives more incentives to local manufacturers as boost to local production of pharmaceutical products.en
dc.description.sponsorshipUniversity of Nairobien
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.subjectSupply chainen
dc.subjectpharmaceuticalsen
dc.subjectKenyaen
dc.titlePharmaceutical Producers and Users Perceptions of the Role of Distributors in the Industry


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record